Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

Consumer Defensive Tobacco
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

Global Legal Cannabis Sales Projected to Grow

PR Newswire September 19, 2017

22nd Century Technology is a “Game Changer”

Business Wire August 23, 2017

22nd Century Group Files 2017 Second Quarter Report and Announces Conference Call to Provide Business Update

Business Wire August 9, 2017

FDA's Plan to Lower Nicotine in Cigarettes Has Captured the Attention of Regulators and Public Health Experts Around the World

Business Wire August 9, 2017

18 Biggest Mid-Day Gainers For Monday

Benzinga.com  August 7, 2017

FDA's Plan to Lower Nicotine in Cigarettes to Non-Addictive Levels Shines Spotlight on 22nd Century Group

Business Wire July 31, 2017

How These Biotech Stocks are Performing? -- Intrexon, 22nd Century, Corcept Therapeutics, and Achaogen

PR Newswire July 26, 2017

The Next Gold Rush is Green

PR Newswire July 20, 2017

Where the Smart Money is Looking This Summer

PR Newswire July 18, 2017

22nd Century Joins Russell Microcap® Index

Business Wire June 26, 2017

Watch These 7 Huge Call Purchases In Monday Trade

Benzinga.com  June 26, 2017

22nd Century Receives Guidance from FDA on Phase III Clinical Trials

Business Wire June 22, 2017

22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands

Business Wire June 20, 2017

22nd Century Meets with FDA on Modified Risk Tobacco Product Application for World’s Lowest Nicotine Tobacco Cigarettes

Business Wire June 16, 2017

New International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes

Business Wire June 15, 2017

Legal Cannabis Sales Grow in North America

PR Newswire June 13, 2017

22nd Century and Dent Neurosciences Research Center to Partner on Brain Imaging Clinical Trial

Business Wire June 8, 2017

22nd Century Produces Non-GMO Very Low Nicotine Tobacco

Business Wire June 6, 2017

Biotech Stock Performance Review -- 22nd Century, Calithera Biosciences, Five Prime Therapeutics, and Advaxis

PR Newswire June 5, 2017

22nd Century Group Receives Order for 2.4 Million SPECTRUM® U.S. Government Research Cigarettes

Business Wire June 1, 2017